Afficher la notice abrégée

dc.contributor.authorAvila, Jesús
dc.contributor.authorÁngel Medina, Miguel
dc.date.accessioned2025-03-07T21:02:41Z
dc.date.available2025-03-07T21:02:41Z
dc.date.issued2011
dc.date.submitted2021-06-02T10:03:37Z
dc.identifierONIX_20210602_10.5772/16879_44
dc.identifierhttps://library.oapen.org/handle/20.500.12657/48929
dc.identifier.urihttps://doab-dev.siscern.org/handle/20.500.12854/166723
dc.description.abstractPhysiological & neuro-psychology, biopsychology
dc.languageEnglish
dc.rightsopen access
dc.subject.classificationbic Book Industry Communication::J Society & social sciences::JM Psychology::JMM Physiological & neuro-psychology, biopsychology
dc.subject.otherSociety & social sciences
dc.subject.otherthema EDItEUR::J Society and Social Sciences::JM Psychology::JMM Physiological and neuro-psychology, biopsychology
dc.titleChapter The Role of Glycogen Synthase Kinase-3 (GSK-3) in Alzheimer’s Disease
dc.typechapter
oapen.identifier.doi10.5772/16879
oapen.relation.isPublishedBy035ecc65-6737-43cf-a13a-6bdf67ce01f4
dc.relationisFundedByFP7-HEALTH-2007-B


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée